• Philip Morris to acquire Fertin Pharma for $812.8m pharmaceutical-business-review
    July 02, 2021
    Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn).
  • Piramal Pharma completes acquisition of Hemmo Pharmaceuticals expresspharma
    June 24, 2021
    Piramal Pharma has completed the acquisition of Hemmo Pharmaceuticals, according to a statement released by the company.
  • Danaher To Acquire Aldevron for $9.6B contractpharma
    June 22, 2021
    Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
  • Solvias Acquires Chemic Labs contractpharma
    June 21, 2021
    Solvias, an analytical testing, contract research, development and manufacturing company, has acquired Chemic Laboratories, Inc. based in Canton, MA.
  • Premier Research Acquires Camargo Pharmaceutical Services contractpharma
    May 24, 2021
    ​Premier Research has acquired Camargo Pharmaceutical Services based in Cincinnati, OH.
  • CD&R to acquire UDG Healthcare for $3.7bn pharmaceutical-technology
    May 14, 2021
    Private equity firm Clayton, Dubilier & Rice (CD&R) has agreed to acquire Ireland-based UDG Healthcare for a total of $3.7bn (£2.6bn) in cash.
  • Emmes Acquires Orphan Reach contractpharma
    May 13, 2021
    ​Emmes, a global, full-service CRO, has acquired Orphan Reach, a company headquartered in the UK with offices in Ireland, Germany, India, Canada, and the U.S., dedicated to clinical research in rare diseases.
  • AstraZeneca Shareholders Approve Proposed Acquisition of Alexion americanpharmaceuticalreview
    May 12, 2021
    A requisite majority of AstraZeneca shareholders has approved the proposal to acquire the entire common stock of Alexion Pharmaceuticals, Inc. (Alexion) at a general meeting.
  • Crown Bioscience Acquires OcellO contractpharma
    May 08, 2021
    ​Crown Bioscience, a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs, has acquired OcellO B.V., a privately owned contract research organization located in the ...
  • Altasciences Acquires Calvert Laboratories contractpharma
    May 08, 2021
    ​Altasciences, a CRO/CDMO supporting all crucial steps in early-stage drug development, from lead candidate selection to clinical proof of concept, has completed the acquisition of Calvert Laboratories, a preclinical CRO located on the U.S. East Coast.
PharmaSources Customer Service